Chemical Component Summary

Name17-DESMETHOXY-17-N,N-DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN
Synonyms17-DMAG
Identifiers[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-(2-dimethylaminoethylamino)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate
FormulaC32 H48 N4 O8
Molecular Weight616.746
TypeNON-POLYMER
Isomeric SMILESC[C@H]1C[C@@H]([C@@H]([C@H](\C=C(\[C@@H]([C@H](\C=C/C=C(/C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)\C)OC)OC(=O)N)/C)C)O)OC
InChIInChI=1S/C32H48N4O8/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(H2,33,41)(H,35,40)/b11-9-,19-10+,21-16+/t18-,20+,25+,26+,28-,30+/m1/s1
InChIKeyKUFRQPKVAWMTJO-LMZWQJSESA-N

Chemical Details

Formal Charge0
Atom Count92
Chiral Atom Count6
Bond Count93
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB12442 
NameAlvespimycin
Groups investigational
DescriptionAlvespimycin is a derivative of geldanamycin and heat shock protein (HSP) 90 inhibitor. It has been used in trials studying the treatment of solid tumor in various cancer as an antitumor agent. In comparison to the first HSP90 inhibitor tanespimycin, it exhibits some pharmacologically desirable properties such as reduced metabolic liability, lower plasma protein binding, increased water solubility, higher oral bioavailability, reduced hepatotoxicity and superior antitumor activity [A19243].
Synonyms
  • 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
  • Alvespimycin hydrochloride
  • DMAG
  • Alvespimycin
  • 17-DMAG
IndicationInvestigated for use as an antineoplastic agent for solid tumors, advanced solid tumours or acute myeloid leukaemia.
Categories
  • Amides
  • HSP90 Heat-Shock Proteins
  • Lactams
  • Quinones
CAS number467214-20-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Heat shock protein HSP 90-alphaMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELIS...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL383824
PubChem 5288674
ChEMBL CHEMBL383824
ChEBI CHEBI:65324, CHEBI:94772